Skip to content

CDR

Sandoz releases generic of Exelon patch in U.S.

Sandoz releases generic of Exelon patch in U.S.

Sandoz has launched a rivastigmine patch, a treatment for dementia, in the U.S. market. The Novartis subsidiary said Wednesday that its rivastigmine transdermal system is an authorized generic version of the Exelon patch, marketed by Novartis Pharmaceuticals Corp.

J M Smith acquires Integra NV business

J M Smith acquires Integra NV business

J M Smith Corp. has acquired pharmacy-related technology products and services offered by Integra NV and will manage them as a subsidiary called Integra LTC Solutions LLC.

GPhA council works to promote biosimilars

GPhA council works to promote biosimilars

Biosimilars offer tremendous promise for millions of Americans suffering from cancer, rheumatoid arthritis or other diseases, offering lower-cost and highly effective alternatives to costly reference product drugs, also known as biologics.

Perrigo purchases ScarAway brand

Perrigo purchases ScarAway brand

Perrigo Co. plc has acquired the ScarAway scar management brand from Enaltus LLC. Financial terms of the transaction weren’t disclosed. Perrigo said Monday that Scaraway is expected to generate overall 2015 net sales of $10 million, or approximately $3 million for the remainder of the year.

Head & Shoulders lands N.Y. Giants’ Beckham as ambassador

Head & Shoulders lands N.Y. Giants’ Beckham as ambassador

Head & Shoulders has signed up New York Giants wide receiver Odell Beckham as its latest hair ambassador. The Procter & Gamble hair care brand — the official shampoo of the National Football League — said Friday that fans can now see Beckham in his first ad for Head & Shoulders on the

J&J, P&G collaborations target flu, heart disease

J&J, P&G collaborations target flu, heart disease

Johnson & Johnson and Procter & Gamble — are involved in collaborations that could make a big impact in fighting flu and heart disease. Scientists from The Scripps Research Institute (TSRI) and J&J’s Janssen pharmaceutical subsidiary have found a way to induce antibodies to fight a wide range

Aurobindo cleared to market Baraclude generic

Aurobindo cleared to market Baraclude generic

Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for entecavir tablets 0.5 mg and 1 mg, a medication for hepatitis B. Aurobindo, which announced the product this week, said its entecavir tablets are a generic version of Baraclude tablets (0.